Insider Buying: Amrize (NYSE:AMRZ) Insider Purchases $70,680.00 in Stock

Amrize Ltd (NYSE:AMRZ) insider Jaime Hill bought 1,500 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average price of $47.12 per share, for a total transaction of $70,680.00. Following the acquisition, the insider directly owned 29,698 shares of the company’s stock, valued at approximately $1,399,369.76. The trade was a 5.32% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Amrize Trading Down 0.2%

NYSE:AMRZ opened at $46.66 on Friday. The company has a fifty day moving average of $51.21 and a 200 day moving average of $54.47. Amrize Ltd has a 52 week low of $46.03 and a 52 week high of $65.94. The company has a quick ratio of 0.89, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $25.81 billion, a P/E ratio of 21.50, a P/E/G ratio of 1.00 and a beta of 0.11.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The firm had revenue of $3.50 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. On average, research analysts predict that Amrize Ltd will post 2.72 earnings per share for the current year.

Amrize Announces Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize’s dividend payout ratio is 20.28%.

Amrize News Summary

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Multiple insiders bought shares: Executives purchased more than $697,000 of Amrize stock on August 11, including CFO Baris Oran, CTO Roald Brouwer, Stephen S. Clark, Mario Gross and Jaime Hill. The buying may signal that management considers the recent weakness an attractive entry point. Amrize insider buying report
• Positive Sentiment: Stephens maintained a Buy rating on Amrize, reinforcing the view that the building-materials company has longer-term upside potential. Stephens maintains Buy rating
• Positive Sentiment: Amrize declared a quarterly dividend of $0.11 per share, payable August 26 to shareholders of record August 18. The dividend provides modest income support, although the ex-dividend date may contribute to near-term trading volatility.
• Neutral Sentiment: Jefferies initiated coverage with a Hold rating, giving investors a cautious view that offsets some of the optimism from Stephens and the insider purchases. Jefferies gives Amrize a Hold rating
• Negative Sentiment: Amrize’s latest quarterly earnings missed expectations, with EPS of $0.88 versus the $0.92 consensus estimate. Revenue was $3.50 billion, while analysts expect full-year EPS of $2.72, keeping earnings execution a concern.

Institutional Investors Weigh In On Amrize

Several institutional investors and hedge funds have recently modified their holdings of AMRZ. Norges Bank bought a new stake in shares of Amrize during the 4th quarter valued at about $929,333,000. Harris Associates L P purchased a new position in shares of Amrize during the fourth quarter valued at about $615,406,000. Wellington Management Group LLP raised its stake in Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after buying an additional 3,809,133 shares in the last quarter. Marshall Wace LLP raised its stake in Amrize by 865.4% in the third quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock worth $139,436,000 after buying an additional 2,590,336 shares in the last quarter. Finally, Barclays PLC raised its stake in Amrize by 95.4% in the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after buying an additional 2,253,431 shares in the last quarter.

Analyst Ratings Changes

Several analysts recently issued reports on AMRZ shares. Citigroup cut their target price on Amrize from $66.00 to $58.00 and set a “buy” rating on the stock in a research note on Tuesday, August 11th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Royal Bank Of Canada cut Amrize from a “sector perform” rating to an “underperform” rating and dropped their price objective for the stock from $60.00 to $48.00 in a report on Monday, August 10th. Vertical Research upgraded Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a research report on Friday, May 1st. Finally, Oppenheimer reduced their target price on Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $60.57.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.